Cocrystal Pharma Inc (COCP)

[mick]

$COCP reading dd & your theory

re;
News: $COCP Are These Penny Stocks A Buy During Earnings Season?

Should You Buy Penny Stocks During Earnings Season?

Penny stocks are hot right now.

If you looked at the stock market today, the Russell 2000 ETF ( IWM ETF Report ) jumped more than 1.6% on August 3rd.

This far-outpaced the S&P 500 ETF ( SPY ETF Report ) as well as the tech-heavy Invesco...

Got this from COCP - Are These Penny Stocks A Buy During Earnings Season?

https://marketwirenews.com/news-releases/are-these-penny-stocks-a-buy-during-earnings-season--4813927339741288.html?i=ib

Penny Stocks To Buy, Sell, Or Hold: Cocrystal Pharma
While this isn’t an earnings catalyst, it could be considered a news catalyst in my opinion.

Cocrystal Pharma (COCP Stock Report) has been on the list of penny stocks to watch for a while now. In fact, COCP stock was one of the first biotech penny stocks that ran big this year.

We first started discussing it in February when it was trading around $0.60. At the time, Cocrystal had just closed a financing deal.

Obviously a lot has happened since then by just looking at the chart. COCP stock ran as high as $2.50 then ended up sliding down to around $0.80 in March.

[Read More] Epicenter Penny Stocks To Watch For August 2020

The company itself isn’t very active on the press wires. But obviously there’ve been a lot of positive developments in the COVID-19 arena. Cocrystal initiated its preclinical studies of COVID-19 inhibitors during Q2 2020.

It further intends to identify more COVID-19 inhibitors utilizing its proprietary platform technology over the course of the second and third quarters of this year.

The company said it planned to identify additional inhibitors using its proprietary platform technology in Q3 2020 and anticipates the selection of its lead preclinical molecule in Q4 2020.

So what’s behind the recent surge? On August 3rd, COCP stock broke out late in the afternoon.

The penny stock ended up closing out at $2.36 and continued even higher after the close. In a release titled, “New published study from K-State virologists identifies potential COVID-19 treatment,” details shed some light on the latest momentum.

Yunjeong Kim and Kyeong-Ok “KC” Chang, virologists in the College of Veterinary Medicine at Kansas State University, have published a study showing a possible therapeutic treatment for COVID-19.

Come to find out, the “new compounds” in the publication are exclusively licensed and being developed by Cocrystal Pharma for COVID-19.